About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Fgfr2tm1Cxd
targeted mutation 1, Chu-Xia Deng
MGI:2153790
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Fgfr2tm1Cxd/Fgfr2tm1Cxd either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss) MGI:2176477
ht2
Fgfr2tm1Cxd/Fgfr2+ either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss) MGI:2176478


Genotype
MGI:2176477
hm1
Allelic
Composition
Fgfr2tm1Cxd/Fgfr2tm1Cxd
Genetic
Background
either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr2tm1Cxd mutation (0 available); any Fgfr2 mutation (90 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes die between E10.5 and E11.5 due to a failure in chorioallantoic fusion or in functional placental formation
• by E11.5, all homozygotes are dead and partially resorbed

embryo
• at E10.5, ~20% of homozygotes are developmentally delayed, with some dying at this stage
• at E9.5, ~20% of homozygotes are smaller than wild-type embryos
• at E10.5, all homozygotes are smaller than wild-type embryos
• at E9.5 and E10.5, all homozygotes fail to display limb bud induction
• at ~ E9-E10.5, about 1/3 of homozygotes display an enlarged allantois that remains unfused with the chorion and appears as a vascular hydropic cyst or a solid mass of varying shapes
• at E9.5, about 1/3 of mutant placentas lack the allantois component and fail to form a connection with the embryo
• at E10.5, some homozygotes exhibit poor placental vascularization due to absence of labyrinthine trophoblast cells
• at E10.5, some homozygotes exhibit placentas without labyrinthine portions due to a nearly complete block in proliferation of trophoblast cells
• such placentas may be partially functional as these embryos appear to survive slightly longer than mutants with no chorioallantoic fusion
• at E9.5, mutant trophoblast cells exhibit a block in proliferation, as shown by PCNA staining (only <5% vs >70% in wild-type cells)
• at E9.5, an expansion of the trophoblast giant cell layer is observed
• at E9.5, mutant spongiotrophoblasts appear somewhat disorganized, though normal in number
• at E10.5-E11.5, about 2/3 of homozygotes show failure of placental development with absence of the labyrinthine portion, despite normal chorioallantoic fusion
• in some cases, the fetal component is thinner and remains as funnel-shaped structures resembling those observed at E9.5
• in other cases, the allantoic mesoderm undergoes vascular differentiation, but most placental blood vessels are abnormally exposed to the surface of placentas due to absence of labyrinthine trophoblast cells
• at ~E8.5-E8.75, about 1/3 of homozygotes show absence of chorioallantoic fusion

limbs/digits/tail
• at E9.5 and E10.5, all homozygotes fail to display limb bud induction

growth/size/body
• at E10.5, ~20% of homozygotes are developmentally delayed, with some dying at this stage
• at E9.5, ~20% of homozygotes are smaller than wild-type embryos
• at E10.5, all homozygotes are smaller than wild-type embryos

hearing/vestibular/ear
• mutant otic vesicles are reduced in size relative to wild-type

cardiovascular system
• at E10.5, some homozygotes exhibit poor placental vascularization due to absence of labyrinthine trophoblast cells




Genotype
MGI:2176478
ht2
Allelic
Composition
Fgfr2tm1Cxd/Fgfr2+
Genetic
Background
either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * NIH Black Swiss)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgfr2tm1Cxd mutation (0 available); any Fgfr2 mutation (90 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• surprisingly, heterozygotes are developmentally normal with no craniofacial or limb defects





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory